This article is copyrighted by GreenMedInfo LLC, 2019
Visit our Re-post guidelines
Visit our Re-post guidelines

Merck has received the FDA’s fast-tracked approval of a live, genetically modified Ebola vaccine which, according to its vaccine insert, can cause a novel new form of Ebola-type infection, resulting in immunosuppression and possible shedding of live virus to others.